Literature DB >> 16198428

Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Boris Sakic1, David L Kirkham, David A Ballok, James Mwanjewe, Ian M Fearon, Joseph Macri, Guanhua Yu, Michelle M Sidor, Judah A Denburg, Henry Szechtman, Jonathan Lau, Alexander K Ball, Laurie C Doering.   

Abstract

Brain atrophy, neurologic and psychiatric (NP) manifestations are common complications in the systemic autoimmune disease, lupus erythematosus (SLE). Here we show that the cerebrospinal fluid (CSF) from autoimmune MRL-lpr mice and a deceased NP-SLE patient reduce the viability of brain cells which proliferate in vitro. This detrimental effect was accompanied by periventricular neurodegeneration in the brains of autoimmune mice and profound in vivo neurotoxicity when their CSF was administered to the CNS of a rat. Multiple ionic responses with microfluorometry and protein peaks on electropherograms suggest more than one mechanism of cellular demise. Similar to the CSF from diseased MRL-lpr mice, the CSF from a deceased SLE patient with a history of psychosis, memory impairment, and seizures, reduced viability of the C17.2 neural stem cell line. Proposed mechanisms of cytotoxicity involve binding of intrathecally synthesized IgG autoantibodies to target(s) common to different mammalian species and neuronal populations. More importantly, these results indicate that the viability of proliferative neural cells can be compromised in systemic autoimmune disease. Antibody-mediated lesions of germinal layers may impair the regenerative capacity of the brain in NP-SLE and possibly, brain development and function in some forms of CNS disorders in which autoimmune phenomena have been documented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198428      PMCID: PMC1634761          DOI: 10.1016/j.jneuroim.2005.08.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  107 in total

1.  Functional maturation of isolated neural progenitor cells from the adult rat hippocampus.

Authors:  Ron C Hogg; Hiram Chipperfield; Kathryn A Whyte; Mark R Stafford; Mitchell A Hansen; Simon M Cool; Victor Nurcombe; David J Adams
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

2.  Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus.

Authors:  O Lechner; Y Hu; M Jafarian-Tehrani; H Dietrich; S Schwarz; M Herold; F Haour; G Wick
Journal:  Brain Behav Immun       Date:  1996-12       Impact factor: 7.217

3.  Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.

Authors:  E Martínez-Cordero; B E Rivera García; D E Aguilar León
Journal:  J Investig Allergol Clin Immunol       Date:  1997 Nov-Dec       Impact factor: 4.333

Review 4.  The new epidemiology of schizophrenia.

Authors:  P Jones; M Cannon
Journal:  Psychiatr Clin North Am       Date:  1998-03

Review 5.  The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions.

Authors:  B S McEwen; C A Biron; K W Brunson; K Bulloch; W H Chambers; F S Dhabhar; R H Goldfarb; R P Kitson; A H Miller; R L Spencer; J M Weiss
Journal:  Brain Res Brain Res Rev       Date:  1997-02

6.  Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.

Authors:  M Farrell; B Sakić; H Szechtman; J A Denburg
Journal:  Lupus       Date:  1997       Impact factor: 2.911

7.  Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6.

Authors:  B Sakić; H Szechtman; T Braciak; C Richards; J Gauldie; J A Denburg
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

8.  High association of anticardiolipin antibodies with psychosis.

Authors:  M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal:  J Clin Psychiatry       Date:  1998-01       Impact factor: 4.384

Review 9.  Lupus and the central nervous system.

Authors:  S G West
Journal:  Curr Opin Rheumatol       Date:  1996-09       Impact factor: 5.006

10.  Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells.

Authors:  James Mwanjewe; Ashok K Grover
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more
  18 in total

Review 1.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

2.  Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.

Authors:  Sivan Gelb; Ariel D Stock; Shira Anzi; Chaim Putterman; Ayal Ben-Zvi
Journal:  J Autoimmun       Date:  2018-04-04       Impact factor: 7.094

3.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution.

Authors:  E Muscal; D R Bloom; J V Hunter; B L Myones
Journal:  Lupus       Date:  2009-12-21       Impact factor: 2.911

5.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

Review 6.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

7.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

8.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09

9.  Disturbed distribution of proliferative brain cells during lupus-like disease.

Authors:  Mile Stanojcic; Tal Burstyn-Cohen; Nadia Nashi; Greg Lemke; Boris Sakic
Journal:  Brain Behav Immun       Date:  2009-06-06       Impact factor: 7.217

Review 10.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.